JD Health First-Half 2026 Revenue Up 15.9%, Non-IFRS Operating Profit Jumps 40.3%
JD Health announced its interim results for 2026 on August 13. First-half revenue rose 15.9% year on year to RMB 40.9 billion, and Non-IFRS operating profit climbed 40.3% to RMB 3.5 billion.
JD Health reported total revenue of RMB 40.9 billion for the first half of 2026, up 15.9% year on year, while operating profit under Non-IFRS reached RMB 3.5 billion, an increase of 40.3%.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Pharmacy Retail, with intensity 50/100 and 60% confidence over a short term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.